LGALS3 and early-onset autosomal dominant Alzheimer disease: Additionally, galectin-3 is implicated in several neuroinflammatory and neurodegenerative processes including multiple sclerosis, Alzheimer’s disease, and stroke, highlighting its potential role as a biomarker for neuroprognostication [41,42,43].